loadpatents
Patent applications and USPTO patent grants for Bondurant; Kristina L..The latest application filed is for "multi-epitope peptide-loaded dendritic cell immunotherapy for cancer".
Patent | Date |
---|---|
Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer Grant 9,783,795 - Cannon , et al. October 10, 2 | 2017-10-10 |
Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme Grant 8,187,587 - O'Brien , et al. May 29, 2 | 2012-05-29 |
Multi-epitope Peptide-loaded Dendritic Cell Immunotherapy For Cancer App 20110038895 - CANNON; MARTIN J. ;   et al. | 2011-02-17 |
Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer Grant 7,846,446 - Cannon , et al. December 7, 2 | 2010-12-07 |
Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme App 20080279872 - O'Brien; Timothy J. ;   et al. | 2008-11-13 |
Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer App 20080152663 - Cannon; Martin J. ;   et al. | 2008-06-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.